Results 331 to 340 of about 413,694 (387)
Current Hepatitis Reports, 2006 Hepatitis B virus (HBV)infection is a major cause of chronic hepatitis and cirrhosis,with an estimated 350 million people worldwide infected with the virus.Despite continuing advances in antiviral therapy,a cure for chronic HBV infection is considered an elusive goal.Thus,primary prevention by immunization with HBV vaccines remains the most effective ...
Henry C. Bodenheimer +2 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-up.
Nephron, 1985Formalin-inactivated hepatitis B vaccine was given at 0, 1 and 6 months to 22 medical staff members and to 37 haemodialysis patients. After vaccination with 20 micrograms surface antigen (HBsAg), seroconversion occurred in 95% of the staff members ...
P. A. D. Graeff +4 more
semanticscholar +1 more source
Trials of intradermal hepatitis B vaccines in Gambian children.
Annals of Tropical Paediatrics, 1987Three trials of intradermal hepatitis B virus (HBV) vaccines were made in Gambian children. In the first trial HBV vaccine (1 microgram) was given to neonates in the same syringe with BCG followed by two further does of 1.0 microgram of intradermal HBV ...
H. Whittle, W. Lamb, R. Ryder
semanticscholar +1 more source
International Archives of Allergy and Applied Immunology, 1988
Yeast-derived hepatitis B vaccines (partially purified or highly purified) at different dosages and a plasma-derived hepatitis B vaccine (control) were injected into 50 young volunteers 3 times at monthly intervals.
G. Wiedermann +9 more
semanticscholar +1 more source
Yeast-derived hepatitis B vaccines (partially purified or highly purified) at different dosages and a plasma-derived hepatitis B vaccine (control) were injected into 50 young volunteers 3 times at monthly intervals.
G. Wiedermann +9 more
semanticscholar +1 more source
Hepatitis B and A vaccines [PDF]
, 1989 Hepatitis has been recognized as a serious disease throughout recorded history. Outbreaks of jaundice came to be recognized over time as potentially infectious in nature. The confirmation of a viral aetiology to certain forms of hepatitis was established in the early 1940s in studies in human volunteers to whom hepatitis could be transmitted by a non ...
P. J. Provost, R. W. Ellis
openaire +1 more source
, 1988 The first results of active immunization against hepatitis B in humans were reported a little over 10 years ago (Maupas et al., 1976). Since then, several serum-derived hepatitis B (HB) vaccines have been proved safe, highly immunogenic and efficacious in various populations at risk (Stevens et al., 1984).
F. Tron +8 more
openaire +1 more source
Immunogenicity of hepatitis B vaccines.
Journal of the American Medical Association (JAMA), 1994To the Editor. —Drs Margolis and Presson1have provided a well-reasoned Editorial on host factors relevant to the suboptimal response to recombinant hepatitis B vaccines (HBVs) observed among adults and reported in that issue ofJAMA.2,3They point out that
R. Koff
semanticscholar +1 more source
Hepatitis B vaccines--to switch or not to switch.
, 1987With the recent licensure of a hepatitis B vaccine prepared in yeast by recombinant DNA technology (Recombivax-HB), a new era in vaccine development has emerged.
Hollinger Fb
semanticscholar +1 more source
Clinics in Liver Disease, 1999
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources
On a global basis, the hepatitis B virus (HBV) is the most important vaccine-preventable liver disease. As a consequence, the development of vaccines for the prevention of HBV represents one of the major achievements of modern medicine. 34 Universal immunization against HBV has been adopted in over 80 countries.
openaire +2 more sources